Watch the webinar “COVID-19 vaccines for myeloma patients: what you need to know.”MPE, Myeloma, Videos30 April 2021
European Commission approves the second indication of isatuximab for relapsed multiple myelomaAccess, Myeloma19 April 2021
Horizon2020 CARAMBA Myeloma Pipeline information sheet now available in five languagesMPE, Myeloma7 April 2021
The FDA approves the first anti-BCMA CAR-T Cell Therapy for myeloma, idecabtagene vicleucel (Abecma)Access, Myeloma31 March 2021
Selinexor receives Conditional Marketing Authorisation in Europe for the treatment of relapsed and or refractory myeloma patientsAccess, Myeloma30 March 2021
The FDA approves melphalan flufenamide for patients with relapsed or refractory myelomaAccess, Myeloma1 March 2021
